Pharmaceutical Business review

Orthofix signs license agreement with TSRHC

True/Lok is a versatile, lightweight system designed to correct limb deformities, treat bone fractures and lengthen limbs using a simpler frame, according to Orthofix International.

In addition to marketing the current True/Lok system, the arrangement provides for Texas Scottish Rite Hospital for Children (TSRHC) and Orthofix to collaborate in the development and marketing of future versions of the True/Lok system introduced to the medical community during the term of the agreement.

Alan Milinazzo, CEO of Orthofix International, said: “This agreement demonstrates the company’s commitment to maintain its role as a significant participant in the global orthopedic fixation market. This collaboration is an important example of our ongoing focus on the development of innovative, minimally invasive treatments around the world.”

Exit mobile version